Global RNA Interference Market 2020 to Expand at a CAGR of 19.35% by Arcturus Therapeutics, Inc., Arrowhead Pharmaceuticals, Inc., Dicerna Pharmaceuticals, Inc
RNA interference market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 56.83 billion by 2027 growing with the CAGR of 19.35% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits associated with the usage of RNA interference for cancer diagnosis has been directly impacting the growth of RNA interference market.
View full press release